Physician profile
Peter J Doelger
NPI 1427153352
$1,261.87
in general payments reported to CMS, 2019-2025
22 companies · $74.33 in 2025
The $74.33 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $453 · 2020: $130 · 2021: $74.36 · 2022: $180 · 2023: $282 · 2024: $68.85 · 2025: $74.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $425.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $425.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $157.17 | 2022-2023 | Lo Loestrin Fe, Liletta |
| Minerva Surgical, INC | $109.62 | 2019-2022 | |
| Pfizer INC. | $105.00 | 2019-2024 | |
| Therapeuticsmd, INC. | $102.31 | 2019-2022 | |
| Duchesnay USA Incorporated | $89.55 | 2019-2020 | |
| Exeltis, USA INC. | $84.45 | 2019-2025 | Slynd |
| Mayne Pharma Commercial LLC | $78.83 | 2023-2024 | |
| Avion Pharmaceuticals | $73.31 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $56.65 | 2019-2025 | |
| Millicent US INC | $56.40 | 2019-2024 | Intrarosa, Femring |
| Amag Pharmaceuticals, INC. | $55.91 | 2019-2020 | |
| Agile Therapeutics, INC. | $40.82 | 2021-2023 | Twirla |
| Astellas Pharma US INC | $36.85 | 2019 | |
| Lupin INC. | $36.13 | 2020 | |
| Myovant Sciences INC. | $32.09 | 2021-2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sage Therapeutics, LLC | $30.38 | 2025 | Zurzuvae |
| Alexion Pharmaceuticals, INC. | $30.11 | 2019 | |
| Hologic Sales and Service, LLC | $23.89 | 2023 | Myosure Tissue Removal Device |
| Organon LLC | $18.99 | 2022 | |
| Coopersurgical, INC. | $15.56 | 2019 | |
| Mylan Pharmaceuticals INC. | $14.73 | 2020 | |
| Allergan, INC. | $13.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Doelger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.